New Revised MRP, 100% GST benefit passed Acrotac 25mg Capsule 20'S
Netmeds First Membership
Quick Links
Introduction About ACROTAC 25MG CAPSULE
ACROTAC 25MG CAPSULE contains Acitretin which belongs to a group of medicines called retinoids. It is used to manage severe skin condition in which the skin has become thick and scaly. These skin problems include the psoriasis, ichthyosis and keratosis follicularis (Darier’s disease). It works by improving the normal growth of the skin. In psoriasis the cells in outer layer of the skin grow more faster than normal with red, irritated, inflamed, thicker skin.
Always take ACROTAC 25MG CAPSULE exactly as prescribed by your doctor. Swallow the medicine whole with plenty of water. It should not be given to children as it may cause changes in bone growth. If it is given to a child, the doctor will decide the correct dose based on the child’s weight.
This medicine is contraindicated in cases of the hypersensitivity (e.g. angioedema, urticaria) to acitretin or to other retinoids. Do not drive or operate any machinery while taking this medicine, particularly at night time since your vision may be affected. Do not take this medicine, if you are pregnant or breastfeeding. It can pass into your milk and may harm your baby. The most common side effects include dry mouth, joint pain, tight muscles, hair loss, dry eyes, rise in blood fats.
Uses Of ACROTAC 25MG CAPSULE
- Used to manage severe skin problems where skin has become thick and may be scaly (Psoriasis, Ichthyosis and keratosis follicularis (Darier’s disease)
How ACROTAC 25MG CAPSULE Works
ACROTAC 25MG CAPSULE works by inhibiting the excessive cell growth and keratinization (process by which skin cells become thickened due to the deposition of a protein within them).
How to use ACROTAC 25MG CAPSULE
Always take ACROTAC 25MG CAPSULE exactly as prescribed by your doctor. Swallow the medicine whole with plenty of water.
Side Effects Of ACROTAC 25MG CAPSULE
Serious
- Allergic reaction with symptoms such as skin rash, swelling or itching of the skin, swelling of the face, lips, throat or tongue
- Severe nasal congestion, asthma or wheezing
- Severe headache
- Feeling or being sick
- Problems with your eyesight
- Aches and pains in muscles, bones or joints
Common
- Dry, irritated or swollen eyes, which may lead to intolerance of contact lenses
- Dry, irritated or runny nose, nose bleeding
- Dry mouth, thirst
- Dryness or inflammation of lips, which may alleviate by application of a fatty ointment.
- Increased level of fats in your blood (shown by blood test)
Rare
- Increased blood pressure in the skull
- Night blindness
- Inflammation of the cornea in eye (ulcerative keratitis)
How To Manage Side Effects
Diarrhea
Drink lot of fluid, such as water or squash, to avoid dehydration. Do not take any other medicine without consulting your doctor.
Headache
Rest and drink plenty of fluids. Apply a cold, wet cloth or ice pack to your forehead. Rest in a quiet, comfortable, dark room.
Nausea And Vomiting
Keep try taking this medicine with, or just after, a meal or snack and stick to simple meals and do not eat rich or spicy food.
Stomach Pain
Try to rest and relax. You can eat and drink slowly or have frequent meals. Keeping a heat pad or a covered hot water pack on your stomach may also help. If still pain persists, speak to your doctor.
Warning & Precautions
Pregnancy
Use with CautionACROTAC 25MG CAPSULE should be used with caution in pregnant women. Consult your doctor before taking this medicine.
Breastfeeding
Use with CautionACROTAC 25MG CAPSULE should be used with caution in breastfeeding women. Consult your doctor before taking this medicine.
Driving and Using Machines
Use with CautionDo not drive or operate any machinery while taking this medicine, particularly at night time since your vision may be affected.
Alcohol
Consult your doctorAvoid consumption of alcohol while taking this medicine.
Kidney
Use with CautionACROTAC 25MG CAPSULE should be taken with caution in patients with severe kidney disease. Consult your doctor for advice.
Liver
Use with CautionACROTAC 25MG CAPSULE should be taken with caution in patients with severe liver disease. Consult your doctor for advice.
Allergy
ContraindicatedDo not take if you are allergic to any of the ingredients of this medicine.
Interactions
Talk to your doctor if you are taking:
- An antibiotic called tetracycline (for an infection)
- Methotrexate (for skin problems, arthritis or cancer)
- Low dose progesterone only contraceptives (minipills)
- Medicines or vitamin supplements
- Other retinoid medicines including isotretinoin or tazarotene
Synopsis
| Drug | : | Acitretin |
| Pharmacological Category | : | Retinoids |
| Therapeutic Indication | : | Psoriasis, Ichthyosis and Keratosis follicularis (Darier’s disease) |
| Dosage Forms | : | Capsule |
More Information
- Store below 20-25°C and keep out of reach of children.
FAQs About ACROTAC 25MG CAPSULE
Is ACROTAC 25MG CAPSULE an immunosuppressant?
No, it is not immunosuppressive, is generally safe for long-term use and has no time limit restrictions, which makes it useful in combination therapy and for maintenance therapy.
What is ACROTAC 25MG CAPSULE taken for?
It is used to manage severe psoriasis (abnormal growth of skin cells that causes red, thickened, or scaly skin). It is in a class of medications called retinoids.
Is ACROTAC 25MG CAPSULE a retinoid?
It is the systemic retinoid used for psoriasis and effective as monotherapy.
References
1. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical, 2011. Page – 1812.
2. Chai Sue Lee, John Koo; A review of acitretin, a systemic retinoid for the management of psoriasis [Published on Aug 2005] [Accessed 2nd July 2024] https://pubmed.ncbi.nlm.nih.gov/16086658/
3. Morningside Pharmaceuticals Ltd; Electronic Medicines Compendium (EMC); [Revised on Oct 2019] [Accessed 2nd July 2024] https://www.medicines.org.uk/emc/files/pil.10292.pdf
4. Sortane; U.S. food and drug administration; [Revised on Sep 2017] [Accessed 2nd July 2024] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019821s028lbl.pdf
Author Details
